Gilde, Omikron, TBG and Athena dig deep.
France’s oldest VC has raised a new fund of E330m for investment in early-stage biotech and IT companies.
Last week's private equity figures showed a steep decline in activity. The value of deals fell 59 per cent to $5.5bn from $13.3bn last quarter. But when PEO quizzed the market, we found PE firms in cheerful mood.
The Munich venture capitalist sells its DM53.5m stake in the Swiss biotech firm after two years. Morgan Stanley placed the shares with institutional investors.
Martin Block joins from the Royal Bank of Scotland.
Geocapital, Apax, Advent, VCF Partners and Chase Episode 1 sign the cheques.
Bank of Scotland finances the deal.
Shares rise on the speculation.
Three groups are working on rival bids but Apax and Hicks Muse are still in front. Any deal will be one of Europe’s biggest ever LBOs.
The venture capitalist has announced a $950m fund aimed at biotech and IT, but not the internet. Institutionals on both sides of the Atlantic contributed to the fund.